A Study of Efficacy and Safety of TLL-018 in CSU Participants

Summary

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TLL-018 in Participants With Moderate-to-Severe Chronic Spontaneous Urticaria (CSU) With Inadequate Controll to Second Generation H1-antihistamines.

Timeline

Start

2024-03-27

Primary completion

2025-10-23

Completion

2026-12-30

Drugs

Indications